The ups and downs of structure-activity landscapes.

Rajarshi Guha
Author Information
  1. Rajarshi Guha: NIH Chemical Genomics Center, Rockville, MD, USA.

Abstract

In this chapter we discuss the landscape view of structure-activity relationships (SARs). The motivation for such a view is that SARs come in a variety of forms, such as those where small changes in structure lead to small changes in activity or where small structural lead to significant changes in activity (also termed activity cliffs). Thus, an SAR dataset is viewed as a landscape comprised of smooth plains, rolling hills, and jagged gorges. We review the history of this view and early quantitative approaches that attempted to encode the landscape. We then discuss some recent developments that directly characterize structure-activity landscapes, in one case with the goal of highlighting activity cliffs while the other allows one to resolve different types of SAR that may be present in a dataset. We highlight some applications of these approaches, such as predictive model development and SAR elucidation, to SAR datasets obtained from the literature. Finally, we conclude with a summary of the landscape approach and why it provides an intuitive and rigorous alternative to standard views of structure-activity data.

References

  1. J Chem Inf Model. 2006 Jul-Aug;46(4):1535 [PMID: 16859285]
  2. J Chem Inf Model. 2005 Sep-Oct;45(5):1237-43 [PMID: 16180900]
  3. J Med Chem. 1996 Aug 2;39(16):3049-59 [PMID: 8759626]
  4. J Chem Inf Model. 2006 Jan-Feb;46(1):180-92 [PMID: 16426054]
  5. Bioorg Med Chem Lett. 2007 Sep 15;17(18):5091-5 [PMID: 17681466]
  6. J Med Chem. 2008 Oct 9;51(19):6075-84 [PMID: 18798611]
  7. J Med Chem. 2007 Nov 15;50(23):5571-8 [PMID: 17902636]
  8. J Chem Inf Model. 2008 Aug;48(8):1716-28 [PMID: 18686944]
  9. J Med Chem. 2006 Nov 16;49(23):6672-82 [PMID: 17154498]
  10. J Chem Inf Model. 2008 Mar;48(3):646-58 [PMID: 18303878]
  11. J Med Chem. 2009 Feb 26;52(4):1075-80 [PMID: 19140668]
  12. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1549-52 [PMID: 16386422]
  13. Bioorg Med Chem Lett. 2007 Sep 15;17(18):5165-70 [PMID: 17629702]
  14. Bioorg Med Chem. 2007 Aug 1;15(15):5166-76 [PMID: 17544282]

Grants

  1. ZIB HG200319-07/Intramural NIH HHS

MeSH Term

Algorithms
Animals
Biological Assay
Dose-Response Relationship, Drug
Enzyme Inhibitors
Humans
Linear Models
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Models, Molecular
Phosphorylation
Principal Component Analysis
Receptor, Melanocortin, Type 4
Receptors, Glucocorticoid
Structure-Activity Relationship

Chemicals

Enzyme Inhibitors
Receptor, Melanocortin, Type 4
Receptors, Glucocorticoid
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3

Word Cloud

Created with Highcharts 10.0.0landscapestructure-activityactivitySARviewsmallchangesdiscussSARsleadcliffsdatasetapproacheslandscapesonechapterrelationshipsmotivationcomevarietyformsstructurestructuralsignificantalsotermedThusviewedcomprisedsmoothplainsrollinghillsjaggedgorgesreviewhistoryearlyquantitativeattemptedencoderecentdevelopmentsdirectlycharacterizecasegoalhighlightingallowsresolvedifferenttypesmaypresenthighlightapplicationspredictivemodeldevelopmentelucidationdatasetsobtainedliteratureFinallyconcludesummaryapproachprovidesintuitiverigorousalternativestandardviewsdataupsdowns

Similar Articles

Cited By